Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topical versus intravenous tranexamic acid in total knee arthroplasty
ACTRN12614000582651Phase 3Completed
- Sponsor
- SAMUEL J MACDESSI
- Start
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tranexamic acid in Bleeding (2 arms), sponsored by SAMUEL J MACDESSI. Primary endpoint: Reduction in hemoglobin drop. Started Jul 2014; status: completed.
02
Drugs
tranexamic acid
03
Conditions
Bleeding
Beyond the preview
Go deeper on ACTRN12614000582651.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000582651.